A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.

Trial Profile

A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ACTRA-RI
  • Most Recent Events

    • 05 Jan 2015 Status changed from active, no longer recruiting to completed as reported in the results published in the Annals of the Rheumatic Diseases.
    • 27 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top